Search PubMed⌕ Search

Biomedical subjects

H Gu

Publications and source records attributed to H Gu.

At least 145 records · Page 8Linked to original sources

A phage display system for studying the sequence determinants of protein folding.

We have developed a phage display system that provides a means to select variants of the IgG binding domain of peptostreptococcal protein L that fold from large combinatorial libraries. The premise underlying the selection scheme is that binding of protein L to IgG requires that the protein be properly folded. Using a combination of molecular biological and biophysical methods, we show that this assumption is valid. First, the phage selection procedure strongly selects against a point mutation in protein L that disrupts folding but is not in the IgG binding interface. Second, variants recovered from a library in which the first third of protein L was randomized are properly folded. The degree of sequence variation in the selected population is striking: the variants have as many as nine substitutions in the 14 residues that were mutagenized. The approach provides a selection for "foldedness" that is potentially applicable to any small binding protein.

Amino Acid Sequence↗

Transcriptional repression of fibronectin gene expression in v-src transformation.

V-src-dependent and -independent alterations in the steady-state content, rates of synthesis, and turnover of fibronectin protein and mRNA were identified using rat fibroblasts which are temperature sensitive for p60v-src activity. Activation of p60v-src caused a fivefold reduction in the rate of fibronectin biosynthesis. The v-src-dependent decrease in fibronectin biosynthesis resulted from a similar reduction in the steady-state content of fibronectin mRNA. This change was reversible and required more than 24 h, implying an indirect effect of p60v-src on fibronectin gene expression. The rate of fibronectin mRNA turnover and pattern of alternative splicing were unchanged following p60v-src activation, indicating that these regulatory steps are insensitive to v-src transformation. A v-src-specific reduction of at least threefold was measured for the rate of fibronectin gene transcription, and gene transfer studies using fibronectin promoter-CAT reporter genes indicated that transcriptional repression occurs at the level of initiation. When p60v-src was inactive, CAT reporter genes controlled by 4.9 or 3.2 kb of the rat fibronectin promoter exhibited relatively increased CAT activity (approximately twofold) compared to another CAT reporter construction controlled by only 880 bp of the fibronectin promoter. In contrast, CAT activity was relatively reduced (approximately twofold) for the reporter constructions containing 4.9 or 3.2 kb of the promoter when p60v-src was active. These findings indicate that the distal portion of the fibronectin promoter contains a v-src-sensitive element(s) which mediates a decrease in the rate of fibronectin transcription initiation by negative control.

Animals↗

[Some biochemical indexes in white rabbit's blood affected by acute high intensity microwave].

Irradiation of white rabbits by 10, 50, 100 and 200 mW/cm2 microwave respectively can cause the disorder of protein metabolism, the abnormality of blood sugar, and the change of the activity of serum alpha-hydroxybutyrate dehydrogenase, lactate dehydrogenase, glutamic oxalacetic transaminase, glutamic pyruvic transaminase, acid phosphatase ect. These changes can be used as indexes in the evaluation of the effect of acute high intensity microwave exposure. The effect on the organism mainly depends on the intensity of exposure provided the dose of microwave remains the same.

Acid Phosphatase↗

Experimental study on the model of coronary artery thrombosis in dog.

We have developed a model of coronary artery thrombosis in dog by using the method stimulating coronary adventitia with direct current. The results have shown that the thrombi are similar to human artery thrombi in composition and the model of coronary artery thrombosis is satisfactory and the time of forming thrombosis is shorter than that by other methods.

Animals↗

[The effect of sodium prasterone sulfate on lactation].

To study the relationship between sodium prasterone sulfate and lactation, blood samples were collected from 120 cases. Sixty cases were in study group (at different periods: during the 3rd trimester, and 1st, 3rd day postpartum) including 30 cases using 100mg sodium prasterone sulfate, 30 cases (using 200mg sodium prasterone sulfate), 60 cases were in control group. The serum levels of estradiol (E2), prolactin (PRL) and plasma levels of oxytocin (OT) were measured by radioimmunoassay, and the production of breast milk was observed. The results showed no statistically significant difference of serum E2, PRL and plasma OT between (sodium prasterone sulfate) study groups and control groups, and the production of breast milk indicated also no significant difference between the 2 groups. The conclusion is that low-dose sodium prasterone sulfate (200mg/day, 600mg/week) did not affect the production of breast milk.

Adult↗

Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.

LLC-PK1 cells have been stably transfected with cDNAs encoding the human norepinephrine transporter (NET), rat dopamine transporter (DAT), and rat serotonin transporter. Using these cell lines, the specificity of each transporter toward agents that inhibit substrate influx and stimulate substrate efflux across the plasma membrane was examined. With 1-methyl-4-phenylpyridinium as a substrate for DAT and NET and serotonin as a substrate for the serotonin transporter, each transporter demonstrated a distinct pattern of inhibition by a panel of amphetamine derivatives and analogs, including amphetamine, methamphetamine (also known as "ecstasy"), p-chloroamphetamine, 3,4-methylenedioxymethamphetamine, methylphenidate (ritalin), and 5-methoxy-6-methyl-2-aminoindan. For each cell line expressing a single biogenic amine transporter, efflux of the accumulated substrate was stimulated by amphetamine derivatives, and this efflux was blocked by mazindol, an inhibitor of all three transporters. Of the amphetamine derivatives tested, some caused efflux at concentrations similar to those that inhibited transport. Other derivatives were much less effective at stimulating efflux than at inhibiting uptake. Methylphenidate caused little or no efflux, although it blocked uptake mediated by both NET and DAT. Other inhibitors of transport, such as cocaine, mazindol, citalopram, and nisoxetine, failed to stimulate efflux from these cells at concentrations that inhibited influx. The results suggest that potency toward individual plasma membrane biogenic amine transporters and the ability to release accumulated amine substrates are independent properties of each amphetamine derivative.

1-Methyl-4-phenylpyridinium↗

[Fetal fibronectin diagnosis of premature rupture of the amniotic membranes].

OBJECTIVE: To determine whether fetal fibronectin is a sensitive test for the detection of premature rupture of the amniotic membranes. METHODS: Fetal fibronectin by ABC immunoblotting methods were measured in samples of cervicovaginal secretion from 80 cases with ruptured amniotic membranes (study group) and 50 cases of term pregnancy (control group A). Plasma fetal fibronectin were examined in 30 cases of normal pregnancy (control group B). RESULTS: The detection rate of fetal fibronectin in the women with ruptured membranes was 95.0%, While 6% in normal pregnancy. CONCLUSIONS: Fetal fibronectin is a sensitive test for detection of present of amniotic fluid. It can be used for diagnosis of ruptured amniotic membranes.

Amniotic Fluid↗

Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies.

BACKGROUND: The bacteriophage-derived Cre-loxP recombination system operates efficiently in mammalian cells. This system is particularly useful in gene-targeting experiments in the mouse, and has already been used to generate 'clean' deletions of target genes in the germ line, as well as to inactivate target genes in a conditional manner (based on regulated expression of the Cre recombinase). In principle, Cre-loxP-mediated recombination should also allow gene replacement, and thus the introduction of virtually any kind of mutation into the genome. RESULTS: We used the Cre-loxP system, in mouse embryonic stem cells, to replace the mouse gene C gamma 1, which encodes the constant region of the heavy chain of IgG1 antibodies, with its human counterpart. The mutation was transmitted through the mouse germ line, and the resulting mutant mice were crossed with mice expressing kappa light chains with a human, instead of a mouse, constant region. Mice homozygous for both mutations produce humanized, kappa-chain-bearing IgG1 antibodies at the same level and efficiency as wild-type mice produce murine IgG1 antibodies. These animals should enable the ex vivo production of humanized, chimeric monoclonal antibodies specific for any antigen to which the mouse can respond. CONCLUSIONS: Cre-loxP-mediated gene replacement is a simple and efficient general method of targeted mutagenesis in the mouse.

Animals↗

Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting.

Deletion of the promoter and the first exon of the DNA polymerase beta gene (pol beta) in the mouse germ line results in a lethal phenotype. With the use of the bacteriophage-derived, site-specific recombinase Cre in a transgenic approach, the same mutation can be selectively introduced into a particular cellular compartment-in this case, T cells. The impact of the mutation on those cells can then be analyzed because the mutant animals are viable.

Animals↗

Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody.

Antibodies have been raised against synthetic peptides derived from the predicted primary sequence of the human cocaine- and antidepressant-sensitive norepinephrine (NE) transporter (NET). One antibody (N430), raised and purified against a putative intracellular human norepinephrine transporter (hNET) epitope, detects hNET expression in a stably transfected cell line (LLC-NET) by indirect immunofluorescence only in the presence of detergent, while no immunoreactivity is observed in either the parental cells (LLC-PK1) or in LLC-NET cells incubated with preimmune sera or peptide absorbed antibody. N430 immunoblots of LLC-NET cell extracts reveal two major immunoreactive hNET species in these cells, migrating at 80 and 54 kDa, respectively. Pulse-chase N430 immunoprecipitation studies confirm that the 54-kDa species is a transient, glycosylated intermediate of a longer lived, more highly glycosylated protein with an apparent M(r) of 80,000. In contrast, a 54-kDa species is the primary hNET product in vaccinia virus T7-infected HeLa cells, transiently transfected with hNET cDNA. PNGase F digestion of extracts prepared from LLC-NET- and hNET-transfected HeLa cells convert all immunoreactive species to a 46-kDa form, equivalent to that observed following incubation of whole cells with the glycosylation inhibitor tunicamycin. As transiently transfected HeLa and stable LLC-NET cells exhibit a pharmacologically similar NE transport activity, it appears likely that the additional glycosylation evident in the stable line does not contribute significantly to antagonist sensitivity. On the other hand, NE transport and antagonist ([125I]RTI-55) binding assays on whole LLC-NET cells treated with tunicamycin reveal a pronounced reduction in NE transport activity and hNET membrane density paralleled by an inability of NET proteins to replenish the higher M(r) hNET pool. These findings suggest an obligate role for N-linked glycosylation in hNET biosynthetic maturation, stability, and functional expression. In summary, N430 antibody is a useful tool for the visualization and characterization of hNET gene products and has permitted the first direct evaluation of biosynthetic steps leading to functional catecholamine transporter expression.

Animals↗

Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.

We have constructed stable cell lines expressing transporters for dopamine (DA), norepinephrine (NE), and serotonin (5-HT) by transfection with cloned cDNAs. The parental LLC-PK1 cell does not express any of these neurotransmitter transporters. Therefore, monoamine transport activities in each of these cell lines are due to the transfected DNA only, allowing comparison in the same background. Drug inhibition profiles for each cell line are distinct and as expected for each transporter. LLC-NET and LLC-DAT cells transported both NE and DA and both cell types exhibited a lower KM for DA transport than for NE transport. Analysis of Vmax data for LLC-NET cells suggests that substrate is bound to the NE transporter during the rate-limiting step(s) in transport. The cocaine analog 2-beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binds to each cell type, and is displaced by transport substrate in each case. Binding and transport measurements on parallel cell cultures allowed estimation of turnover numbers for norepinephrine, dopamine, and serotonin transporters. All three transporters require external Na+ and Cl-. The Na+ concentration dependence suggests that a single Na+ ion is involved in transport catalyzed by norepinephrine and serotonin transporters while more than one Na+ ion participate in transport mediated by the dopamine transporter.

Animals↗

Comparison of the effects of antimitotic drugs on alpha-tubulin mRNA, microtubules and nicotinic receptor-mediated catecholamine secretion in adrenal chromaffin cells in culture.

1. Four hour treatments of adrenal chromaffin cells with colchicine (10, 100 microM and 1 mM), tubulozole (10 microM) or podophyllotoxin (100 microM) decreases alpha-tubulin mRNA content. Vinblastine (10 microM) and taxol (10 microM), however, do not decrease alpha-tubulin mRNA content. 2. Immunocytochemical techniques demonstrate that 4 hr treatments with all of the antimitotic drugs (colchicine, podophyllotoxin, taxol, tubulozole and vinblastine) produce abnormal microtubule arrays. 3. The effects of 4 hr treatments with the antimitotic drugs on adrenal catecholamine secretion are all qualitatively the same; each drug selectively inhibits adrenal nicotinic acetylcholine receptor-stimulated catecholamine release, while having no inhibitory actions on release stimulated through noncholinergic mechanisms. 4. These studies demonstrate that autoregulation of tubulin synthesis occurs in cultured adrenal chromaffin cells. 5. All of the antimitotic drugs selectively inhibit nicotinic receptor-mediated adrenal catecholamine release under treatment conditions that affect adrenal microtubules. These results support the possibility that the actions of the antimitotic drugs on adrenal nicotinic receptors may involve microtubules.

Adrenal Medulla↗

Gene targeting and its application to the study of B-cell development.

The use of gene targeting technology for the study of gene functions in vivo continues to expand. The application of this technology as well as further improvements in the technology itself enable us to examine the influence of various genetic elements and gene products on B-lymphocyte development and function.

Animals↗

[Insulin resistance and pregnancy induced hypertension].

Plasma glucose and serum insulin in oral glucose tolerance test (OGTT) were measured in 40 patients with pregnancy induced hypertension (PIH) and 30 normal pregnancies. Compared with the controls, serum insulin concentration, plasma glucose and their area under the curve (AUC) increased in 15 patient with severe PIH, in 0.5, 1, 2, 3 hours postload (P < 0.05) of OGTT. The relationship between diastolic blood pressure and integrated area under the curve for serum insulin concentration (r = 0.35, P < 0.05) were observed in 15 patients with severe PIH. The results indicated that patients with severe PIH are insulin resistant and hyperinsulinemic after an oral glucose load.

Adult↗

[Changes in blood oxytocin levels in cases of pregnancy induced hypertension].

Serial measurements of plasma oxytocin concentration were done by radioimmunoassay in 38 cases of pregnancy induced hypertension (PIH) and 38 cases of normal pregnancy (NP). The results showed that there was no obvious difference in the plasma oxytocin concentration between patients with early PIH and NP, but a higher concentration in cases with PIH at term pregnancy than that in NP and a significantly higher level in intrapartum women with PIH. The results also indicated a much higher oxytocin concentration in cases of moderate and severe PIH as compared to that of NP. An obviously higher level of plasma oxytocin was found in severe PIH than in mild PIH. Based on this study we suggest that the clinical use of oxytocin in cases with PIH should be different from that in NP.

Adult↗

Generation of a mouse strain that produces immunoglobulin kappa chains with human constant regions.

Humanized antibodies are highly efficient as immunotherapeutic reagents and have many advantages over rodent antibodies. A mouse strain was generated by gene targeting to replace the mouse kappa light chain constant (C) region gene with the human C kappa gene. Mice homozygous for the replacement mutation (C kappa R) produced normal concentrations of serum antibodies, most of which carry chimeric kappa light chains, and mounted normal immune responses to hapten-protein conjugates. This technology provides a feasible option for the generation of high-affinity humanized antibodies by means of the powerful somatic hypermutation-selection mechanism.

Amino Acid Sequence↗

Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.

We have employed a method based on the Cre-loxP recombination system of bacteriophage P1 to generate a mouse strain in which the JH segments and the intron enhancer in the IgH locus are deleted. By analysis of immunoglobulin isotype switch recombination in heterozygous mutant B cells activated by lipopolysaccharide plus interleukin-4, we show that, on the mutant chromosome, switch recombination at the mu gene switch region is strongly suppressed, whereas the switch region of the gamma 1 gene is efficiently rearranged. These data demonstrate an independent control of switch recombination at individual switch regions and suggest that, in the process of switch recombination, the alignment of the recombining strands occurs independently of and probably after the introduction of double-strand breaks into the switch regions involved.

Animals↗